Chen et al. [68] observed that 600 mg/day resveratrol for three months in patients with NAFLD (n = 60) reduced insulin resistance (HOMA-IR), glucose, and total cholesterol, LDL, and liver enzymes, such as ALT and AST. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.